Nautilus Biotechnology Inc (NAUT) — Cash Flow Quality Index

Latest as of December 2019: -0.23x

Nautilus Biotechnology Inc (NAUT) has a Cash Flow Quality Index of -0.23x as of December 2019. Operating cash flow of $-88.99K is below net income of $385.49K, suggesting accrual-heavy earnings not yet converted to cash. Explore NAUT strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-0.23x
Operating CF / Net Income

Operating Cash Flow

$-88.99K
USD

Net Income

$385.49K
USD

Data as of

Dec 2019
Most recent filing

Nautilus Biotechnology Inc Cash Flow Quality Index (2018–2018)

Historical Cash Flow Quality Index for Nautilus Biotechnology Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Nautilus Biotechnology Inc to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Nautilus Biotechnology Inc (2018–2018)

Year-by-year earnings quality comparison for Nautilus Biotechnology Inc. For live market cap and the full company financial profile, see Nautilus Biotechnology Inc stock valuation.

Year Quality Index Operating CF (USD) Net Income YoY Change
2018 -0.38x $-238.30 Million $626.60 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.